Back to results

CompletedPhase 3

Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea

NCT01392677

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Research Site

Edmonton, Alberta, Canada

+41 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2011-10
Enrollment: 311 participants
Sponsor: AstraZeneca
Purpose: treatment

Locations (42)

Research SiteEdmonton, Alberta, Canada
Research SiteWinnipeg, Manitoba, Canada
Research SiteSt. John's, Newfoundland and Labrador, Canada
Research SiteHalifax, Nova Scotia, Canada
Research SiteSydney Mines, Nova Scotia, Canada
Research SiteBrampton, Ontario, Canada
Research SiteEtobicoke, Ontario, Canada
Research SiteMarkham, Ontario, Canada
Research SiteSmiths Falls, Ontario, Canada
Research SiteKensington, Prince Edward Island, Canada
Research SiteLaval, Quebec, Canada
Research SiteQuébec, Quebec, Canada
Research SiteBeroun, Czechia
Research SiteČeské Budějovice, Czechia
Research SiteJílové u Prahy, Czechia
Research SitePrague, Czechia
Research SiteSemily, Czechia
Research SiteVyškov, Czechia
Research SiteAßlar, Germany
Research SiteBerlin, Germany
Research SiteDresden, Germany
Research SiteFalkensee, Germany
Research SiteNeuwied, Germany
Research SitePirna, Germany
Research SiteKielce, Poland
Research SiteLodz, Poland
Research SiteLublin, Poland
Research SitePoznan, Poland
Research SiteWarsaw, Poland
Research SiteZgierz, Poland
Research SiteBanská Bystrica, Slovakia
Research SiteKošice, Slovakia
Research SitePovažská Bystrica, Slovakia
Research SiteRimavská Sobota, Slovakia
Research SiteBarcelona, Catalonia, Spain
Research SiteSanta Coloma de Gramanet (bcn), Catalu?a, Spain
Research SiteA Coruña, Galicia, Spain
Research SiteOviedo, Principality of Asturias, Spain
Research SiteA Coruña, Spain
Research SiteBarcelona, Spain
Research SiteOviedo, Spain
Research SiteSanta Coloma de Gramenet (bcn), Spain

Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea — TrialFind